Nov 7 (Reuters) - Clover Biopharmaceuticals 2197.HK :
- COMPLETES BLA SUBMISSION FOR SEASONAL INFLUENZA VACCINE IN BRAZIL
- UPON BIOLOGIC LICENSE APPLICATION APPROVAL, WILL WORK WITH LOCAL PARTNER TO COMMERCIALIZE PRODUCT IN BRAZIL
(([email protected];))
News: CLV Clover Biopharmaceuticals Says Completes BLA Submission For Seasonal Influenza Vaccine In...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CLV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.5¢ |
Change
0.005(1.02%) |
Mkt cap ! $82.66M | |||
| Open | High | Low | Value | Volume |
| 48.3¢ | 49.5¢ | 48.0¢ | $22.77K | 47.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 30459 | 48.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 49.5¢ | 17514 | 2 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| CLV (ASX) Chart |